These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
457 related items for PubMed ID: 19474717
1. Short bowel syndrome: the role of GLP-2 on improving outcome. Wallis K, Walters JR, Gabe S. Curr Opin Clin Nutr Metab Care; 2009 Sep; 12(5):526-32. PubMed ID: 19474717 [Abstract] [Full Text] [Related]
3. Acute effects of the glucagon-like peptide 2 analogue, teduglutide, on intestinal adaptation in short bowel syndrome. Thymann T, Stoll B, Mecklenburg L, Burrin DG, Vegge A, Qvist N, Eriksen T, Jeppesen PB, Sangild PT. J Pediatr Gastroenterol Nutr; 2014 Jun; 58(6):694-702. PubMed ID: 24399211 [Abstract] [Full Text] [Related]
4. [Short bowel syndrome. GLP-2 analog teduglutide]. Storr M. Med Monatsschr Pharm; 2013 Sep; 36(9):343-5. PubMed ID: 24069647 [No Abstract] [Full Text] [Related]
5. Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome. Martin GR, Wallace LE, Sigalet DL. Am J Physiol Gastrointest Liver Physiol; 2004 Jun; 286(6):G964-72. PubMed ID: 14962847 [Abstract] [Full Text] [Related]
6. Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome. Yazbeck R. Curr Opin Mol Ther; 2010 Dec; 12(6):798-809. PubMed ID: 21154171 [Abstract] [Full Text] [Related]
7. Gut hormones, and short bowel syndrome: the enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation. Martin GR, Beck PL, Sigalet DL. World J Gastroenterol; 2006 Jul 14; 12(26):4117-29. PubMed ID: 16830359 [Abstract] [Full Text] [Related]
8. Teduglutide enhances structural adaptation of the small intestinal mucosa in patients with short bowel syndrome. Tappenden KA, Edelman J, Joelsson B. J Clin Gastroenterol; 2013 Aug 14; 47(7):602-7. PubMed ID: 23426461 [Abstract] [Full Text] [Related]
10. New approaches to the treatments of short bowel syndrome-associated intestinal failure. Jeppesen PB. Curr Opin Gastroenterol; 2014 Mar 14; 30(2):182-8. PubMed ID: 24406477 [Abstract] [Full Text] [Related]
11. Teduglutide in intestinal adaptation and repair: light at the end of the tunnel. Mardini HE, de Villiers WJ. Expert Opin Investig Drugs; 2008 Jun 14; 17(6):945-51. PubMed ID: 18491995 [Abstract] [Full Text] [Related]
12. Modern treatment of adult short bowel syndrome patients. Efsen E, Jeppesen PB. Minerva Gastroenterol Dietol; 2011 Dec 14; 57(4):405-17. PubMed ID: 22105729 [Abstract] [Full Text] [Related]
13. Synergy of glucagon-like peptide-2 and epidermal growth factor coadministration on intestinal adaptation in neonatal piglets with short bowel syndrome. Lim DW, Levesque CL, Vine DF, Muto M, Koepke JR, Nation PN, Wizzard PR, Li J, Bigam DL, Brubaker PL, Turner JM, Wales PW. Am J Physiol Gastrointest Liver Physiol; 2017 Apr 01; 312(4):G390-G404. PubMed ID: 28104586 [Abstract] [Full Text] [Related]
14. Pharmacologic options for intestinal rehabilitation in patients with short bowel syndrome. Jeppesen PB. JPEN J Parenter Enteral Nutr; 2014 May 01; 38(1 Suppl):45S-52S. PubMed ID: 24615689 [Abstract] [Full Text] [Related]
15. Teduglutide for the treatment of short bowel syndrome. Vipperla K, O'Keefe SJ. Expert Rev Gastroenterol Hepatol; 2011 Dec 01; 5(6):665-78. PubMed ID: 22017694 [Abstract] [Full Text] [Related]